Literature DB >> 19373518

Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels.

Kaire Heilman1, Mihkel Zilmer, Kersti Zilmer, Vallo Tillmann.   

Abstract

The purpose of the study was to investigate bone mineral density (BMD) in children with type 1 diabetes (DM1) and to establish the relationships between BMD, physical activity, glycemic control, and markers of systemic oxidative stress and inflammation. We studied 30 children with DM1, aged 4.7-18.6 years, and 30 healthy subjects, matched by sex, age, and body mass index (BMI). Mean duration of DM1 was 5.4 +/- 3.4 years and mean glycosylated hemoglobin (HbA(1c)) level over 12 months was 9.8 +/- 1.5%. Lumbar and total bone mineral density (BMD, g/cm(2)) were measured by dual-energy X-ray absorptiometry (DXA). We calculated the apparent volumetric lumbar BMD (BMDvol, g/cm(3)) and total mineral content adjusted for age and height (BMCadj), and measured plasma intercellular adhesion molecule-1 (ICAM-1), high sensitivity C-reactive protein (hs-CRP), and urinary 8-iso-prostaglandin F(2a) (F(2)-IsoPs). Calcium (Ca) intake was assessed by questionnaire and physical activity by questionnaire and accelerometer (ActiGraph, count/h). Total BMCadj and lumbar BMDvol were significantly lower in children with DM1 than in controls (101.8 +/- 7.7 vs. 107 +/- 5.7%, P = 0.005; 0.32 +/- 0.08 vs. 0.36 +/- 0.09 g/cm(3), P = 0.05, respectively). These differences were mostly caused by the differences in boys. Plasma ICAM-1 and hs-CRP levels were significantly higher in the DM1 group compared to the controls. Ca intake and urine F(2)-IsoPs levels were similar between the groups. Diabetic boys were less active than controls (18231 +/- 6613 vs. 24145 +/- 7449 count/h, P = 0.04). In the DM1 group, lumbar BMDvol correlated inversely with urinary F(2)-IsoPs (r = -0.5; P = 0.005) and plasma ICAM-1 levels (r = -0.4; P = 0.02), and also with HbA(1c) levels after adjustment for age (r = -0.45; P < 0.05). Total BMCadj correlated inversely with HbA(1c) levels (r = -0.4; P = 0.02). We conclude that children with DM1, particularly boys, have lower BMD. Poor glycemic control, elevated markers of oxidative stress, and inflammation are associated with lower BMD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373518     DOI: 10.1007/s00774-009-0076-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  35 in total

1.  Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty.

Authors:  J T Warner; F J Cowan; F D Dunstan; W D Evans; D K Webb; J W Gregory
Journal:  Acta Paediatr       Date:  1998-03       Impact factor: 2.299

2.  Association between oxidative stress and bone mineral density.

Authors:  S Basu; K Michaëlsson; H Olofsson; S Johansson; H Melhus
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

3.  A simple method to assess exercise behavior in the community.

Authors:  G Godin; R J Shephard
Journal:  Can J Appl Sport Sci       Date:  1985-09

4.  Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.

Authors:  P Gunczler; R Lanes; M Paoli; R Martinis; O Villaroel; J R Weisinger
Journal:  J Pediatr Endocrinol Metab       Date:  2001-05       Impact factor: 1.634

5.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.

Authors:  N Mody; F Parhami; T A Sarafian; L L Demer
Journal:  Free Radic Biol Med       Date:  2001-08-15       Impact factor: 7.376

Review 6.  Negative consequences of glycation.

Authors:  M Brownlee
Journal:  Metabolism       Date:  2000-02       Impact factor: 8.694

7.  Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement.

Authors:  Juliane Léger; Daniela Marinovic; Corinne Alberti; Sophie Dorgeret; Didier Chevenne; Claire Lévy Marchal; Nadia Tubiana-Rufi; Guy Sebag; Paul Czernichow
Journal:  J Clin Endocrinol Metab       Date:  2006-07-18       Impact factor: 5.958

8.  Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology.

Authors:  H Kröger; P Vainio; J Nieminen; A Kotaniemi
Journal:  Bone       Date:  1995-08       Impact factor: 4.398

Review 9.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

10.  Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures.

Authors:  Amos A Fatokun; Trevor W Stone; Robert A Smith
Journal:  Neurosci Lett       Date:  2007-02-24       Impact factor: 3.046

View more
  27 in total

1.  Bone status in adolescents with type 1 diabetes.

Authors:  A P Chobot; A Haffke; J Polanska; Z P Halaba; G Deja; P Jarosz-Chobot; W Pluskiewicz
Journal:  Diabetologia       Date:  2010-05-09       Impact factor: 10.122

Review 2.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 3.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

Review 4.  A critical review of diabetes, glycemic control, and dental implant therapy.

Authors:  Thomas W Oates; Guy Huynh-Ba; Adriana Vargas; Peggy Alexander; Jocelyne Feine
Journal:  Clin Oral Implants Res       Date:  2011-11-24       Impact factor: 5.977

5.  Relationship between chronic transfusion therapy and body composition in subjects with thalassemia.

Authors:  Ellen B Fung; Yan Xu; Janet L Kwiatkowski; Maria G Vogiatzi; Ellis Neufeld; Nancy Olivieri; Elliott P Vichinsky; Patricia J Giardina
Journal:  J Pediatr       Date:  2010-06-12       Impact factor: 4.406

Review 6.  Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.

Authors:  V V Zhukouskaya; C Eller-Vainicher; A P Shepelkevich; Y Dydyshko; E Cairoli; I Chiodini
Journal:  J Endocrinol Invest       Date:  2015-04-12       Impact factor: 4.256

Review 7.  Assessment of bone quality in patients with diabetes mellitus.

Authors:  N Jiang; W Xia
Journal:  Osteoporos Int       Date:  2018-05-07       Impact factor: 4.507

8.  Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms.

Authors:  Kannikar Wongdee; Narattaphol Charoenphandhu
Journal:  World J Diabetes       Date:  2011-03-15

9.  Greater inflammation and adiposity are associated with lower bone mineral density in youth with type 1 diabetes.

Authors:  Namrata Sanjeevi; Leah M Lipsky; Tonja R Nansel
Journal:  Diabetes Res Clin Pract       Date:  2018-08-13       Impact factor: 5.602

10.  Glycemic variability predicts inflammation in adolescents with type 1 diabetes.

Authors:  Robert P Hoffman; Amanda S Dye; Hong Huang; John A Bauer
Journal:  J Pediatr Endocrinol Metab       Date:  2016-10-01       Impact factor: 1.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.